Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting.
BACKGROUND
Treatment satisfaction with a loading phase of monthly injections for 3 months followed by a pro-re-nata regimen of ranibizumab in neovascular age-related macular degeneration (nAMD) remains unclear.


OBJECTIVE
The aim was to evaluate the treatment satisfaction of persons with nAMD treated with ranibizumab in a real-life setting.


METHODS
A cross-sectional study was conducted across three eye clinics within the National Health Service in the UK, where treatment is provided free at point of contact.


METHODS
A total of 250 patients were selected randomly for the study. Treatment satisfaction was assessed using the Macular Treatment Satisfaction Questionnaire. Data were collected on satisfaction of the service provided (Client Service Questionnaire-8) and the patients' demographic and quality of life and treatment history. Factors governing treatment questionnaire were determined.


RESULTS
The most important factors that determined the satisfaction were the service provided at the clinic (Client Service Questionnaire-8), health-related quality of life (EQ-5D-3L), and duration of AMD. Visual acuity changes were rated as less important than one would have expected.


CONCLUSIONS
The study result suggested that treatment satisfaction for nAMD was governed by the perception of being reviewed and injected regularly over a long period of time than the actual change in visual acuity from the treatment.
National Institute for Health Research Moorfields Biomedical Research Centre, London, UK; Diabetes Nursing, King's College London, London, UK.
Rishma
R
Gohil
National Institute for Health Research Moorfields Biomedical Research Centre, London, UK; Diabetes Nursing, King's College London, London, UK.
Roxanne
R
Crosby-Nwaobi
Diabetes Nursing, King's College London, London, UK.
Angus
A
Forbes
Ophthalmology Department, James Paget University Hospital, Great Yarmouth, UK.
Ben J
BJ
Burton
National Institute for Health Research Moorfields Biomedical Research Centre, London, UK.
Philip
P
Hykin
National Institute for Health Research Moorfields Biomedical Research Centre, London, UK; Laser and Retinal Research Unit, King's College Hospital, London, UK.
Sobha
S
Sivaprasad
macular treatment satisfaction questionnaire; patient related outcome measure; quality of life; treatment history